drugset / Trial / NCT00092807

Sitosterolemia Extension Study (0653-003)(COMPLETED)

NCT00092807

Phase 3 Completed 37 enrolled Organon and Co
Treatment

Summary

This is an extension study for patients having unusually high absorption of non-cholesterol sterols, resulting in heart-related diseases. This study will evaluate the long term safety and the ability to lower cholesterol levels with an investigational drug.

Timeline

Start
2001-02-12
Primary completion
2001-09-18
Completion
2004-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown